Article Details

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio

Retrieved on: 2021-07-01 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio. View article details on hiswai:

Excerpt

... locally at the tumor site with no hepatotoxicity or systemic side effects that are commonly seen with 4-1BB monoclonal antibodies when used alone.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up